- Home
- QBTS vs IPHA Comparison
QBTS vs IPHA Comparison
Compare QBTS & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QBTS
- IPHA
- Stock Information
- Founded
- QBTS 1999
- IPHA 1999
- Country
- QBTS Canada
- IPHA France
- Employees
- QBTS N/A
- IPHA N/A
- Industry
- QBTS Retail: Computer Software & Peripheral Equipment
- IPHA Biotechnology: Pharmaceutical Preparations
- Sector
- QBTS Technology
- IPHA Health Care
- Exchange
- QBTS Nasdaq
- IPHA Nasdaq
- Market Cap
- QBTS 1.4B
- IPHA 148.3M
- IPO Year
- QBTS N/A
- IPHA 2019
- Fundamental
- Price
- QBTS $6.10
- IPHA $1.77
- Analyst Decision
- QBTS Strong Buy
- IPHA Strong Buy
- Analyst Count
- QBTS 6
- IPHA 1
- Target Price
- QBTS $6.38
- IPHA $11.50
- AVG Volume (30 Days)
- QBTS 105.3M
- IPHA 38.4K
- Earning Date
- QBTS 11-14-2024
- IPHA 03-20-2025
- Dividend Yield
- QBTS N/A
- IPHA N/A
- EPS Growth
- QBTS N/A
- IPHA N/A
- EPS
- QBTS N/A
- IPHA N/A
- Revenue
- QBTS $9,424,000.00
- IPHA $36,202,722.00
- Revenue This Year
- QBTS $4.94
- IPHA N/A
- Revenue Next Year
- QBTS $63.93
- IPHA $101.65
- P/E Ratio
- QBTS N/A
- IPHA N/A
- Revenue Growth
- QBTS 14.27
- IPHA N/A
- 52 Week Low
- QBTS $0.73
- IPHA $1.29
- 52 Week High
- QBTS $11.41
- IPHA $3.51
- Technical
- Relative Strength Index (RSI)
- QBTS 49.13
- IPHA 47.64
- Support Level
- QBTS $5.91
- IPHA $1.63
- Resistance Level
- QBTS $7.11
- IPHA $1.78
- Average True Range (ATR)
- QBTS 1.15
- IPHA 0.10
- MACD
- QBTS -0.28
- IPHA -0.02
- Stochastic Oscillator
- QBTS 34.43
- IPHA 48.57
About QBTS D-Wave Quantum Inc.
D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. The Company's mission is to unlock the power of quantum computing today to benefit business and society. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the Company's LeapTM cloud service.
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.